Leukotrienes as Modifiers of Preclinical Atherosclerosis?
Preclinical atherosclerosis represents a crucial period associated with several pathophysiological reactions in the vascular wall. Failure to diagnose preclinical atherosclerosis at this stage misses a major opportunity to prevent the long-term consequences of this disease. Surrogate biological and...
Saved in:
Main Authors: | Graziano Riccioni, Magnus Bäck |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/2012/490968 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leukotrienes in Atherosclerosis: New Target Insights and Future Therapy Perspectives
by: Graziano Riccioni, et al.
Published: (2009-01-01) -
Cytokine-Leukotriene Receptor Interactions
by: Marek Rola-Pleszczynski, et al.
Published: (2007-01-01) -
Role of Leukotrienes on Protozoan and Helminth Infections
by: Alexandre P. Rogerio, et al.
Published: (2012-01-01) -
Functional Properties and Molecular Architecture of Leukotriene A4 Hydrolase, a Pivotal Catalyst of Chemotactic Leukotriene Formation
by: Jesper Z. Haeggström, et al.
Published: (2002-01-01) -
The Role of Leukotriene Receptor Signaling in Inflammation and Cancer
by: Ramin Massoumi, et al.
Published: (2007-01-01)